Arrhythmias in the muscular dystrophies

被引:85
|
作者
Groh, William J. [1 ]
机构
[1] Indiana Univ, Dept Med, Div Cardiol, Krannert Inst Cardiol, Indianapolis, IN 46202 USA
关键词
Muscular dystrophy; Arrhythmia; Cardiomyopathy; Sudden death; Genetics; Pacemaker; Implantable cardioverter-defibrillator; CARDIAC MAGNETIC-RESONANCE; LAMIN-A/C GENE; MYOTONIC-DYSTROPHY; SUDDEN-DEATH; HEART; CARDIOMYOPATHY; SURVIVAL; TYPE-1; MECHANISMS; MORTALITY;
D O I
10.1016/j.hrthm.2012.06.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The muscular dystrophies are a group of inherited diseases affecting skeletal muscle that also affect cardiac muscle. Cardiac involvement occurs as a degenerative process with fibrosis and fatty replacement of the myocardium. Electrophysiologists are asked to participate in the care of muscular dystrophy patients because of the risk of atrial arrhythmias, conduction disease, bradycardia, ventricular arrhythmias, and sudden death. Duchenne, Becker, and limb-girdle types 2C-2F and 2I are muscular dystrophies in which the development of a dilated cardiomyopathy is common. Arrhythmias and conduction disease occur after the development of the dilated cardiomyopathy. Patients are considered for pacemakers or implantable cardioverter-defibrillators on the basis of guidelines used for nonischemic cardiomyopathies. Myotonic types 1 and 2, Emery-Dreifuss, limb-girdle type 1B, and facioscapulohumeral muscular dystrophies present with conduction disease and associated arrhythmias and variably with a dilated cardiomyopathy. In myotonic type 1, Emery-Dreifuss, and limb-girdle type 1B muscular dystrophies, conduction abnormalities are frequent and often require pacing. Recent studies support the use of prophylactic implantable cardioverter-defibrillators rather than pacemakers. In all the muscular dystrophies, respiratory muscle involvement can impact quality and quantity of life and needs to be factored in when considering a prophylactic device.
引用
收藏
页码:1890 / 1895
页数:6
相关论文
共 50 条
  • [21] Role of CMR Imaging in Diagnostics and Evaluation of Cardiac Involvement in Muscle Dystrophies
    Blaszczyk, Edyta
    Groeschel, Jan
    Schulz-Menger, Jeanette
    CURRENT HEART FAILURE REPORTS, 2021, 18 (04) : 211 - 224
  • [22] Muscular Dystrophies and Neurologic Diseases that Present as Myopathy
    Quan, Dianna
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2011, 37 (02) : 233 - +
  • [23] Cardiac involvement in muscular dystrophies: Molecular mechanisms
    Goodwin, FC
    Muntoni, F
    MUSCLE & NERVE, 2005, 32 (05) : 577 - 588
  • [24] Cardiac involvement in a cross-sectional cohort of myotonic dystrophies and other skeletal myopathies
    Schmid, Johannes
    Beer, Meinrad
    Berghold, Andrea
    Stojakovic, Tatjana
    Scharnagl, Hubert
    Dieplinger, Benjamin
    Quasthoff, Stefan
    Binder, Josepha S.
    Rainer, Peter P.
    ESC HEART FAILURE, 2020, 7 (04): : 1900 - 1908
  • [25] Limb girdle muscular dystrophies
    Finsterer, J
    NERVENARZT, 2004, 75 (12): : 1153 - +
  • [26] Congenital Myopathies and Muscular Dystrophies
    Gilbreath, Heather R.
    Castro, Diana
    Lannaccone, Susan T.
    NEUROLOGIC CLINICS, 2014, 32 (03) : 689 - +
  • [27] Patterns of cardiac involvement in different muscular dystrophies assessed by magnetic resonance imaging
    Goebel, Juliane
    Schult, Karolin
    Schara, Ulrike
    Neudorf, Ulrich
    Forsting, Michael
    Schlosser, Thomas
    Nassenstein, Kai
    ACTA RADIOLOGICA, 2023, 64 (02) : 605 - 611
  • [28] The Muscular Dystrophies
    Flanigan, Kevin M.
    SEMINARS IN NEUROLOGY, 2012, 32 (03) : 255 - 263
  • [29] The electrocardiogram: A useful screening test for cardiac involvement in some but not all of the muscular dystrophies
    Groh, William J.
    HEART RHYTHM, 2010, 7 (10) : 1489 - 1490
  • [30] Muscular dystrophies
    Neuen-Jacob, E.
    PATHOLOGE, 2009, 30 (05): : 357 - 364